This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Treatment of primary ovarian failure

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Managing premature ovarian insufficiency

  • offer sex steroid replacement with a choice of HRT or a combined hormonal contraceptive to women with premature ovarian insufficiency, unless contraindicated (for example, in women with hormone-sensitive cancer)

  • NICE suggest that a clinician should explain to women with premature ovarian insufficiency:
    • the importance of starting hormonal treatment either with HRT or a combined hormonal contraceptive and continuing treatment until at least the age of natural menopause (unless contraindicated)
    • that the baseline population risk of diseases such as breast cancer and cardiovascular disease increases with age and is very low in women aged under 40
    • that HRT may have a beneficial effect on blood pressure when compared with a combined oral contraceptive that both HRT and combined oral contraceptives offer bone protection
    • that HRT is not a contraceptive

  • consider referring women with premature ovarian insufficiency to healthcare professionals who have the relevant experience to help them manage all aspects of physical and psychosocial health related to their condition.

Reference:

  1. Menopause: diagnosis and management. NICE Guideline (November 2015 - last updated December 2019)

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.